AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

NASDAQ:OMEDOncomed Pharmaceuticals SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.89
0.00 (0.00 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.89
Now: $0.89
$0.89
50-Day Range
$0.89
MA: $0.89
$0.89
52-Week Range
$0.55
Now: $0.89
$3.35
VolumeN/A
Average Volume768,904 shs
Market Capitalization$34.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

SEC Filings

Oncomed Pharmaceuticals (NASDAQ:OMED) SEC Filings

DateFilerForm TypeView
05/03/2019
3:30 PM
Oncomed Pharmaceuticals (Filer)
Form 15-12B
04/26/2019
3:45 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13D/A
04/24/2019
10:56 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/24/2019
10:55 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/24/2019
10:54 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/24/2019
10:52 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/24/2019
10:51 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/24/2019
10:49 AM
Oncomed Pharmaceuticals (Filer)
Form S-8 POS
04/23/2019
3:17 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
3:16 PM
Hager Alicia J. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:16 PM
Oncomed Pharmaceuticals (Issuer)
ROOT JONATHAN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
LASERSOHN JACK W (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
Oncomed Pharmaceuticals (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
Oncomed Pharmaceuticals (Issuer)
Stagg Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
3:15 PM
KARSEN PERRY A (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:00 AM
Oncomed Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
04/17/2019
2:26 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
2:24 PM
Oncomed Pharmaceuticals (Subject)
Form 425
03/20/2019
4:04 PM
Oncomed Pharmaceuticals (Filer)
Form DEFM14A
03/15/2019
3:40 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13D
03/15/2019
7:34 AM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
03/15/2019
6:03 AM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
6:01 AM
Oncomed Pharmaceuticals (Subject)
Form 425
03/12/2019
8:27 AM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
03/07/2019
3:10 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2019
7:59 AM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
02/15/2019
5:50 AM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
02/14/2019
3:43 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
5:58 AM
HARBOURVEST PARTNERS LLC (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G
02/13/2019
6:52 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2019
6:51 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2019
10:23 AM
Oncomed Pharmaceuticals (Subject)
Phase4 Partners Ltd (Filed by)
Form SC 13G/A
02/12/2019
11:39 AM
DELPHI VENTURES VIII LP (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2019
3:02 PM
Oncomed Pharmaceuticals (Subject)
Form 425
02/08/2019
2:56 PM
Oncomed Pharmaceuticals (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
01/28/2019
3:05 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
10:50 AM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/26/2018
3:35 PM
Gurney Austin (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
6:00 AM
HARBOURVEST PARTNERS LLC (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G
12/17/2018
3:16 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13D
12/11/2018
12:16 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/06/2018
1:28 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/06/2018
1:27 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/06/2018
1:27 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/06/2018
1:26 PM
Mereo Biopharma Group plc (Filed by)
Oncomed Pharmaceuticals (Subject)
Form 425
12/06/2018
6:05 AM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
6:03 AM
Oncomed Pharmaceuticals (Subject)
Form 425
11/01/2018
3:21 PM
Oncomed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
3:07 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
3:10 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2018
6:00 PM
Oncomed Pharmaceuticals (Issuer)
Stagg Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
5:59 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
5:57 PM
Gurney Austin (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
5:56 PM
Hager Alicia J. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
5:55 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2018
6:44 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2018
6:42 PM
Gurney Austin (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2018
6:41 PM
Oncomed Pharmaceuticals (Issuer)
Stagg Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2018
6:40 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2018
6:38 PM
Hager Alicia J. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2018
11:00 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
7:05 AM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2018
3:54 PM
Oncomed Pharmaceuticals (Filer)
Form CT ORDER
08/02/2018
7:46 AM
Oncomed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
7:30 AM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2018
3:05 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K/A
06/25/2018
5:11 PM
Oncomed Pharmaceuticals (Issuer)
WYZGA MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:10 PM
Oncomed Pharmaceuticals (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:09 PM
Oncomed Pharmaceuticals (Issuer)
Pollard-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:09 PM
KARSEN PERRY A (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:08 PM
LASERSOHN JACK W (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:07 PM
Oncomed Pharmaceuticals (Issuer)
ROOT JONATHAN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
5:07 PM
Oncomed Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:15 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
11:15 PM
Oncomed Pharmaceuticals (Filer)
Form EFFECT
05/25/2018
3:15 PM
Oncomed Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/26/2018
5:14 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
5:13 PM
Oncomed Pharmaceuticals (Issuer)
Stagg Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
5:13 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
5:12 PM
Gurney Austin (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
5:11 PM
Hager Alicia J. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
4:04 PM
Oncomed Pharmaceuticals (Issuer)
Stagg Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2018
4:28 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
4:27 PM
Li Yvonne (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2018
5:42 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
7:40 AM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
8:31 PM
Oncomed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2018
3:06 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2018
5:26 AM
Oncomed Pharmaceuticals (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/23/2018
5:39 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
1:36 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
1:05 PM
DELPHI VENTURES VIII LP (Filed by)
Oncomed Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2018
6:57 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/31/2018
3:04 PM
Oncomed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2018
1:56 PM
Oncomed Pharmaceuticals (Subject)
US VENTURE PARTNERS VIII L P (Filed by)
Form SC 13G/A
01/08/2018
6:09 PM
Oncomed Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
6:08 PM
Lewicki John A. (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
6:07 PM
Gurney Austin (Reporting)
Oncomed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.